Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,351 | 455 | 61.3% |
| Travel and Lodging | $1,851 | 4 | 15.4% |
| Consulting Fee | $1,850 | 2 | 15.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $740.00 | 2 | 6.2% |
| Education | $201.37 | 12 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus America Inc. | $3,880 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $1,392 | 105 | $0 (2024) |
| ABBVIE INC. | $1,136 | 70 | $0 (2024) |
| Gyrus ACMI, Inc. | $740.00 | 2 | $0 (2018) |
| PFIZER INC. | $644.57 | 44 | $0 (2024) |
| 180 Medical, Inc. | $404.24 | 25 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $275.26 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $270.45 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $239.51 | 12 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $238.43 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,045 | 54 | ABBVIE INC. ($262.53) |
| 2023 | $1,203 | 66 | AbbVie Inc. ($223.27) |
| 2022 | $1,155 | 70 | Astellas Pharma US Inc ($170.48) |
| 2021 | $1,005 | 61 | Astellas Pharma US Inc ($228.48) |
| 2020 | $563.94 | 36 | Astellas Pharma US Inc ($221.52) |
| 2019 | $729.66 | 51 | Astellas Pharma US Inc ($196.87) |
| 2018 | $1,219 | 56 | Gyrus ACMI, Inc. ($370.00) |
| 2017 | $5,073 | 81 | Olympus America Inc. ($3,701) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.66 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: CONTINENCE CARE | ||||||
| 10/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/09/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Urology Gynecology | ||||||
| 07/29/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: CONTINENCE CARE | ||||||
| 07/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,270 | 2,879 | $346,392 | $115,030 |
| 2022 | 14 | 2,117 | 2,668 | $301,553 | $116,991 |
| 2021 | 20 | 2,436 | 3,268 | $449,929 | $152,261 |
| 2020 | 22 | 2,017 | 2,737 | $365,790 | $114,156 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 477 | $76,320 | $38,888 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 368 | 407 | $46,805 | $23,408 | 50.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 68 | 80 | $32,000 | $12,536 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $19,490 | $8,068 | 41.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 19 | $19,000 | $5,818 | 30.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 57 | 68 | $27,200 | $3,949 | 14.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 20 | 69 | $13,800 | $3,101 | 22.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 289 | 363 | $30,855 | $2,607 | 8.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 735 | 1,026 | $15,390 | $2,209 | 14.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $4,000 | $2,013 | 50.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 24 | $21,030 | $2,009 | 9.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 30 | $3,600 | $1,835 | 51.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 16 | 16 | $13,920 | $1,608 | 11.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,000 | $1,508 | 50.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,060 | $1,283 | 41.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 21 | $4,200 | $1,113 | 26.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $6,000 | $1,088 | 18.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 17 | 20 | $1,400 | $817.52 | 58.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 73 | 84 | $672.00 | $650.72 | 96.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 27 | $1,350 | $283.40 | 21.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 11 | 11 | $3,300 | $236.40 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 410 | 488 | $78,080 | $42,395 | 54.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 115 | 146 | $58,400 | $23,597 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 300 | 335 | $38,525 | $20,046 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 88 | 88 | $22,385 | $9,462 | 42.3% |
About Dr. Mark Doerr, MD
Dr. Mark Doerr, MD is a Urology healthcare provider based in Orchard Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477560738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Doerr, MD has received a total of $11,994 in payments from pharmaceutical and medical device companies, with $1,045 received in 2024. These payments were reported across 475 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,351).
As a Medicare-enrolled provider, Doerr has provided services to 8,840 Medicare beneficiaries, totaling 11,552 services with total Medicare billing of $498,437. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Orchard Park, NY
- Active Since 08/01/2006
- Last Updated 08/31/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477560738
Products in Payments
- Olympus Digital Flexible Ureteroscopes (Device) $3,355
- XTANDI (Drug) $937.18
- LUPRON DEPOT (Drug) $500.73
- BOTOX (Biological) $497.78
- Myrbetriq (Drug) $451.61
- Not Applicable (Device) $370.00
- Olympus Stone Baskets and Retrievers (Device) $370.00
- GEMTESA (Drug) $367.30
- Olympus Stents (Device) $345.93
- MYRBETRIQ (Drug) $324.53
- Androgel (Drug) $295.59
- KEYTRUDA (Biological) $270.45
- ELIGARD (Drug) $252.77
- XIAFLEX (Biological) $238.43
- ORGOVYX (Drug) $164.75
- GENTLECATH (Device) $152.15
- GENTLECATH GLIDE (Device) $151.92
- JELMYTO (Drug) $144.59
- Olympus Laser Devices (Device) $136.25
- ERLEADA (Drug) $133.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Orchard Park
Dr. Matthew Brennan, Do, DO
Urology — Payments: $78,344
Dr. Anthony Ricottone, M.d, M.D
Urology — Payments: $7,955
Michael Hanzly, Do, DO
Urology — Payments: $7,302
Matthew Sheldon, Md, MD
Urology — Payments: $6,339
Dr. Phillip Seereiter, M.d, M.D
Urology — Payments: $4,896
Valerie Burkhard, M.d, M.D
Urology — Payments: $3,995